Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 08, 2018 01:00 ET | Source: ObsEva SA

ObsEva Reports Second Quarter 2018 Financial Results and Provides Business Update

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Phase 2b EDELWEISS clinical trial...
July 31, 2018 01:30 ET | Source: ObsEva SA

ObsEva SA to Hold Second Quarter 2018 Financial Results and Business Update Call on August 8, 2018

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Geneva, Switzerland and Boston, MA -...
July 25, 2018 01:30 ET | Source: ObsEva SA

ObsEva Expands Executive Team Hiring a Chief Commercial Officer

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Geneva, Switzerland and Boston, MA -...
July 13, 2018 01:30 ET | Source: ObsEva SA

ObsEva SA to start trading today on the SIX Swiss Exchange

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Trading of ObsEva's shares on SIX...
July 06, 2018 01:30 ET | Source: ObsEva SA

ObsEva SA Shares to Begin Trading on SIX Swiss Exchange

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Listing of 45'381'252 registered...
June 20, 2018 02:49 ET | Source: ObsEva SA

ObsEva Announces Pricing of Follow-on Public Offering

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Geneva, Switzerland and Boston, MA -...
June 18, 2018 16:31 ET | Source: ObsEva SA

ObsEva Announces Launch of Proposed Follow-on Public Offering

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Geneva, Switzerland and Boston, MA -...
June 18, 2018 07:00 ET | Source: ObsEva SA

ObsEva SA Achieves Primary and Secondary Endpoints for EDELWEISS Phase 2b Clinical Trial of Linzagolix (OBE2109) in Women with Endometriosis

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Partial suppression of estradiol...
June 15, 2018 16:00 ET | Source: ObsEva SA

ObsEva SA to Hold Investor Call to Announce Topline Results of the EDELWEISS Phase 2b Clinical Trial of Linzagolix (OBE2109) in Women with Endometriosis-Associated Pain on Monday June 18, 2018

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Geneva, Switzerland and Boston, MA - June...
June 01, 2018 07:00 ET | Source: ObsEva SA

ObsEva SA to Seek SIX Share Listing

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Geneva, Switzerland and Boston, MA...